A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor Activity
Open accessAbstract
p53 has a key role in the negative regulation of cell proliferation, in the maintenance of genomic stability, and in the suppression of transformation and tumorigenesis. To identify novel regulators of p53, we undertook two functional screens to isolate genes which bypassed either p53-mediated growth arrest or apoptosis. In both screens, we isolated cDNAs encoding macrophage migration inhibitory factor (MIF), a cytokine that was shown previously to exert both local and systemic proinflammatory activities. Treatment with MIF overcame p53 activity in three different biological assays, and suppressed its activity as a transcriptional activator. The observation that a proinflammatory cytokine, MIF, is capable of functionally inactivating a tumor suppressor, p53, may provide a link between inflammation and tumorigenesis.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
MIF is a potent cytokine that overcomes p53 function by suppressing its transcriptional activity.
“MIF is a potent cytokine that overcomes p53 function by suppressing its transcriptional activity33.”
From Inflammation and cancer (2002) · cites this paper as [33]
Tetracycline-regulated expression of wild-type p53 (GFP tagged) in the TGP53-4 mouse cell line caused a significant decline in endogenous PGM activity.
“tetracycline regulated expression of wild-type p53 (GFP tagged) in the TGP53-4 mouse cell line (27) caused a significant decline in endogenous PGM activity (Fig. 5B).”
From Glycolytic Enzymes Can Modulate Cellular Life Span (2005) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508 · see citing works
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321 · see citing works
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651 · see citing works
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138 · see citing works
NITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J. D., Xie, Q. W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,184 · see citing works
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063 · see citing works
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761 · see citing works
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691 · see citing works
Self-citationp53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864 · see citing works
Transcriptional Activation by Tetracyclines in Mammalian Cells
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H. (1995) · Science · doi:10.1126/science.7792603 · Cited by 2,488 · cited 1× · see citing works
“the tetracycline inducible system (22), and pBabe-puro-tet-GFP-”
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,338 · see citing works
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271 · see citing works
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079 · see citing works
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985 · see citing works
Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
Kuerbitz, S. J., Plunkett, B., Walsh, W., & Kastan, M. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7491 · Cited by 1,837 · see citing works
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801 · see citing works
mdm2 expression is induced by wild type p53 activity.
Barak, Y., Juven, T., Haffner, R., & Oren, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05678.x · Cited by 1,290 · see citing works
Radiation-induced cell cycle arrest compromised by p21 deficiency
Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., & Hannon, G. J. (1995) · Nature · doi:10.1038/377552a0 · Cited by 1,242 · cited 1× · see citing works
“nology), MDM2 (SMP-14; Santa Cruz Biotechnology), Bax (BAX D p21; Santa Cruz Biotechnology), or p21 (23) followed by a horseradish peroxidase–conjugated anti–mouse antibody, and”
BackgroundSelf-citationUV Irradiation Stimulates Levels of p53 Cellular Tumor Antigen in Nontransformed Mouse Cells
Maltzman, W., & Czyzyk, L. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.9.1689 · Cited by 893 · see citing works
Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis
Weitzman, S., & Gordon, L. I. (1990) · Blood · doi:10.1182/blood.v76.4.655.655 · Cited by 761 · see citing works
A role for both RB and p53 in the regulation of human cellular senescence*1
SHAY, J. (1991) · Experimental Cell Research · doi:10.1016/0014-4827(91)90453-2 · Cited by 757 · see citing works
An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.
Bacher, M., Metz, C. N., Calandra, T., Mayer, K., Chesney, J. A., Lohoff, M. D., Gemsa, D., Donnelly, T. M., & Bucala, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7849 · Cited by 664 · see citing works
Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
Moll, U. M., RIOU, G. F., & Levine, A. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.7262 · Cited by 575 · see citing works
Wagner, A. J., Kokontis, J. M., & Hay, N. (1994) · Genes & Development · doi:10.1101/gad.8.23.2817 · Cited by 540 · see citing works
Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53
Jenkins, J. R., Rudge, K., & Currie, G. A. (1984) · Nature · doi:10.1038/312651a0 · Cited by 538 · see citing works
twist is a potential oncogene that inhibits apoptosis
Maestro, R., Tos, A. P. D., Hamamori, Y., Krasnokutsky, S., Sartorelli, V., Kedes, L., Doglioni, C., Beach, D. H., & Hannon, G. J. (1999) · Genes & Development · doi:10.1101/gad.13.17.2207 · Cited by 516 · see citing works
Self-citation(1993) · PubMed · Cited by 469 · see citing works
Cyclin G is a transcriptional target of the p53 tumor suppressor protein.
Okamoto, K., & Beach, D. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06807.x · Cited by 455 · see citing works
Self-citationPhagocytes as Carcinogens: Malignant Transformation Produced by Human Neutrophils
Weitzman, S. A., Weitberg, A. B., Clark, E. P., & Stossel, T. P. (1985) · Science · doi:10.1126/science.3975611 · Cited by 440 · see citing works
Moll, U. M., LaQuaglia, M. P., Bénard, J., & RIOU, G. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4407 · Cited by 426 · see citing works
Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways
Meßmer, U. K., & Brüne, B. (1996) · Biochemical Journal · doi:10.1042/bj3190299 · Cited by 284 · see citing works
Stimulated Human Phagocytes Produce Cytogenetic Changes in Cultured Mammalian Cells
Weitberg, A. B., Weitzman, S. A., Destrempes, M. M., Latt, S. A., & Stossel, T. P. (1983) · New England Journal of Medicine · doi:10.1056/nejm198301063080107 · Cited by 261 · see citing works
UV Irradiation Stimulates Levels of p53 Cellular Tumor Antigen in Nontransformed Mouse Cells
Maltzman, W., & Czyzyk, L. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.9.1689-1694.1984 · Cited by 226 · see citing works
Calandra, T., & Bucala, R. (1997) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v17.i1.30 · Cited by 220 · see citing works
p53; from inductive signal to cellular effect
Hansen, R., & Oren, M. (1997) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(97)80108-6 · Cited by 212 · see citing works
Schaffer, C. J., & Nanney, L. B. (1996) · International review of cytology · doi:10.1016/s0074-7696(08)61986-5 · Cited by 136 · see citing works
ONODERA, S., Suzuki, K., MATSUNO, T., Kaneda, K., TAKAGI, M., & Nishihira, J. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.00311.x · Cited by 119 · see citing works
Meßmer, U. K., & Brüne, B. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0085 · Cited by 97 · see citing works
MaRX: An Approach to Genetics in Mammalian Cells
Hannon, G. J., Sun, P., Carnero, A., Xie, L. Y., Maestro, R., Conklin, D. S., & Beach, D. (1999) · Science · doi:10.1126/science.283.5405.1129 · Cited by 93 · see citing works
Self-citationHibi, K., Mitomi, H., Koizumi, W., Tanabe, S., Saigenji, K., & Okayasu, I. (1997) · American Journal of Clinical Pathology · doi:10.1093/ajcp/108.1.26 · Cited by 90 · see citing works
Helicobacter pylori infection and gastric lymphoma
Wotherspoon, A. (1998) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011683 · Cited by 77 · see citing works
Absence of p53 permits propagation of mutant cells following genotoxic damage
Griffiths, S. D., Clarke, A. R., Healy, L. E., Ross, G., Ford, A. M., Hooper, M. L., Wyllie, A. H., & Greaves, M. F. (1997) · Oncogene · doi:10.1038/sj.onc.1200871 · Cited by 76 · see citing works
Maestro, R., Gloghini, A., Doglioni, C., Gasparotto, D., Vukosavljevic, T., Re, V. D., Laurino, L., Carbone, A., & Boiocchi, M. (1995) · Blood · doi:10.1182/blood.v85.11.3239.bloodjournal85113239 · Cited by 35 · see citing works
Self-citationKrishna, M., Woda, B. A., Savas, L., Baker, S., & Banner, B. F. (1995) · PubMed · Cited by 31 · see citing works
Norris, P. S., & Haas, M. (1997) · Oncogene · doi:10.1038/sj.onc.1201406 · Cited by 21 · see citing works
Flagged first, then by citations
3 of the 48 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Christen S. Hagen T.M. Shigenaga M.K. Ames B.N. Chronic infection and inflammation lead to cancer Parsonnet J. Horning S. Microbes and MalignancyInfection as a Cause of Cancer 1999 Oxford University Press Oxford
Cited by
Sorted by citations
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · see citing works
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111 · see citing works
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399 · see citing works
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746 · see citing works
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,365 · see citing works
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1703 · Cited by 3,091 · see citing works
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,882 · see citing works
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180 · see citing works
Macrophage migration inhibitory factor: a regulator of innate immunity
Calandra, T., & Roger, T. (2003) · Nature reviews. Immunology · doi:10.1038/nri1200 · Cited by 1,799 · see citing works
Cytokines in cancer pathogenesis and cancer therapy
Dranoff, G. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1252 · Cited by 1,567 · see citing works
Inflammation, a Key Event in Cancer Development
Lu, H., Ouyang, W., & Huang, C. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0261 · Cited by 1,031 · see citing works
MIF Signal Transduction Initiated by Binding to CD74
Leng, L., Metz, C. N., Fang, Y., Xu, J., Donnelly, S., Baugh, J., Delohery, T., Chen, Y., Mitchell, R. A., & Bucala, R. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030286 · Cited by 1,154 · see citing works
T he P athogenesis of O ral L ichen P lanus
Sugerman, P. B., Savage, N. W., Walsh, L. J., Zhao, Z. Z., Zhou, X. J., Khan, A., Seymour, G. J., & Bigby, M. E. (2002) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130201300405 · Cited by 766 · see citing works
Candido, J., & Hagemann, T. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9847-0 · Cited by 745 · see citing works
CD44 Is the Signaling Component of the Macrophage Migration Inhibitory Factor-CD74 Receptor Complex
Shi, X., Leng, L., Wang, T., Wang, W., Du, X., Li, J., McDonald, C., Chen, Z., Murphy, J. W., Lolis, E., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.020 · Cited by 679 · see citing works
Glycolytic Enzymes Can Modulate Cellular Life Span
Kondoh, H., Lleonart, M. E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Carnero, A., & Beach, D. (2005) · Cancer Research · doi:10.1158/0008-5472.177.65.1 · Cited by 647 · see citing works
Self-citationInflammation as a Tumor Promoter in Cancer Induction
Philip, M., Rowley, D. A., & Schreiber, H. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.06.006 · Cited by 640 · see citing works
Mitchell, R. A., Liao, H., Chesney, J. A., Fingerle‐Rowson, G., Baugh, J. A., David, J. R., & Bucala, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012511599 · Cited by 617 · see citing works
Chronic immune activation and inflammation as the cause of malignancy
O'Byrne, K. J., & Dalgleish, A. G. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1943 · Cited by 542 · see citing works
Contributions of Age-Related Thymic Involution to Immunosenescence and Inflammaging
Thomas, R., Wang, W., & Su, D.-M. (2020) · Immunity & Ageing · doi:10.1186/s12979-020-0173-8 · Cited by 442 · see citing works
Stark, K., Eckart, A., Haidari, S., Tirniceriu, A., Lorenz, M., von Brühl, M.-L., Gärtner, F., Khandoga, A. G., Legate, K. R., Pless, R., et al. (2013) · Nature Immunology · doi:10.1038/ni.2477 · Cited by 447 · see citing works
A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1
Wang, Y., An, R., Umanah, G. K., Park, H., Nambiar, K., Eacker, S. M., Kim, B., Bao, L., Harraz, M. M., Chang, C., et al. (2016) · Science · doi:10.1126/science.aad6872 · Cited by 421 · see citing works
Ursolic acid: An anti‐ and pro‐inflammatory triterpenoid
Ikeda, Y., Murakami, A., & Ohigashi, H. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700389 · Cited by 417 · see citing works
Cytokines in cancer immunity and immunotherapy
Smyth, M. J., Cretney, E., Kershaw, M. H., & Hayakawa, Y. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00199.x · Cited by 413 · see citing works
Lue, H., Thiele, M., Franz, J., Dahl, E., Speckgens, S., Leng, L., Fingerle-Rowson, G., Bucala, R., Lüscher, B., & Bernhagen, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210318 · Cited by 385 · see citing works
Coussens, L. M., & Werb, Z. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.f23 · Cited by 384 · see citing works
Migratory neighbors and distant invaders: tumor-associated niche cellsPreprint
Wels, J., Kaplan, R. N., Rafii, S., & Lyden, D. C. (2008) · Genes & Development · doi:10.1101/gad.1636908 · Cited by 381 · see citing works
Fehniger, T. A., Suzuki, K., Ponnappan, A., VanDeusen, J. B., Cooper, M. A., Florea, S. M., Freud, A. G., Robinson, M. L., Durbin, J. E., & Caligiuri, M. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.219 · Cited by 373 · see citing works
Baugh, J. A., Chitnis, S., Donnelly, S. C., Monteiro, J., Lin, X., Plant, B. J., Wolfe, F., Gregersen, P. K., & Bucala, R. (2002) · Genes and Immunity · doi:10.1038/sj.gene.6363867 · Cited by 360 · see citing works
Nitric oxide-induced cellular stress and p53 activation in chronic inflammation
Hofseth, L. J., Saito, S., Hussain, S. P., Espey, M. G., Miranda, K. M., Araki, Y., Jhappan, C., Higashimoto, Y., He, P., Linke, S. P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237083100 · Cited by 355 · see citing works
Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease.
Lue, H., Kleemann, R., Calandra, T., Roger, T., & Bernhagen, J. (2002) · Microbes and infection · doi:10.1016/s1286-4579(02)01560-5 · Cited by 394 · see citing works
MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis
Morand, E. F., Leech, M. T., & Bernhagen, J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2029 · Cited by 347 · see citing works
p53, cancer and the immune response
Blagih, J., Buck, M. D., & Vousden, K. H. (2020) · Journal of Cell Science · doi:10.1242/jcs.237453 · Cited by 333 · see citing works
Macrophage migration inhibitory factor
Baugh, J. A., & Bucala, R. (2002) · Critical Care Medicine · doi:10.1097/00003246-200201001-00004 · Cited by 342 · see citing works
Inflammation and the development of pancreatic cancer
Farrow, B., & Evers, B. M. (2002) · Surgical Oncology · doi:10.1016/s0960-7404(02)00015-4 · Cited by 338 · see citing works
Landi, S., Moreno, V. R., Gioia‐Patricola, L., Guinó, E., Navarro, M., de, J., Capellá, G., & Canzian, F. (2003) · PubMed · Cited by 315 · see citing works
Lubetsky, J. B., Dios, A., Han, J., Aljabari, B., Ruzsicska, B. P., Mitchell, R. A., Lolis, E., & Al‐Abed, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203220200 · Cited by 306 · see citing works
Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared
Rhodes, J. M., & Campbell, B. J. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02194-3 · Cited by 301 · see citing works
Interplay between inflammation and cancer
Khandia, R., & Munjal, A. K. (2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.09.004 · Cited by 292 · see citing works
Gore, Y., Starlets, D., Maharshak, N., Becker-Herman, S., Kaneyuki, U., Leng, L., Bucala, R., & Shachar, I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703265200 · Cited by 291 · see citing works
Macrophages, Inflammation, and Lung Cancer
Conway, E. M., Pikor, L. A., Kung, S. H. Y., Hamilton, M. J., Lam, S. C., Lam, W. L., & Bennewith, K. L. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201508-1545ci · Cited by 285 · see citing works
The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting
Fingerle‐Rowson, G., Petrenko, O., Metz, C. N., Forsthuber, T. G., Mitchell, R. A., Huss, R., Moll, U. M., Müller, W., & Bucala, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533295100 · Cited by 284 · see citing works
Baldwin, A. S. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01095.x · Cited by 277 · see citing works
Meyer‐Siegler, K. L., Iczkowski, K. A., Leng, L., Bucala, R., & Vera, P. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8730 · Cited by 261 · see citing works
Flaster, H. V., Bernhagen, J., Calandra, T., & Bucala, R. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0065 · Cited by 259 · see citing works
Evolving complexity of MIF signaling
Jankauskas, S. S., Wong, D. W. L., Bucala, R., Djudjaj, S., & Boor, P. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.01.006 · Cited by 248 · see citing works
Macrophage migration inhibitory factor (MIF): A promising biomarker
Grieb, G., Merk, M., Bernhagen, J., & Bucala, R. (2010) · Drug News & Perspectives · doi:10.1358/dnp.2010.23.4.1453629 · Cited by 242 · see citing works
Oral lichen planus: Causes, diagnosis and management
Sugerman, P. B., & Sabage, N. (2002) · Australian Dental Journal · doi:10.1111/j.1834-7819.2002.tb00540.x · Cited by 236 · see citing works
CD74: A New Candidate Target for the Immunotherapy of B-Cell Neoplasms
Stein, R., Mattes, M. J., Cardillo, T. M., Hansen, H. J., Chang, C., Burton, J., Govindan, S. V., & Goldenberg, D. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1167 · Cited by 228 · see citing works
Bowel Inflammation as Measured by Fecal Calprotectin
Poullis, A. P., Foster, F., Shetty, A., Fagerhol, M. K., & Mendall, M. A. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-03-0160 · Cited by 224 · see citing works
Mignogna, M. D., Fedele, S., Russo, L. L., Muzio, L. L., & Bucci, E. (2003) · Oral Oncology · doi:10.1016/j.oraloncology.2003.08.001 · Cited by 219 · see citing works
Differential gene expression profiling in human brain tumors
Markert, J. M., Fuller, C. M., Gillespie, G. Y., Bubien, J. K., McLean, L. A., Hong, R. L., Lee, K., Gullans, S. R., Mapstone, T. B., & Benos, D. J. (2001) · Physiological Genomics · doi:10.1152/physiolgenomics.2001.5.1.21 · Cited by 219 · see citing works
Rei, M., Gonçalves‐Sousa, N., Lança, T., Thompson, R. G., Mensurado, S., Balkwill, F. R., Kulbe, H., Pennington, D. J., & Silva‐Santos, B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403424111 · Cited by 217 · see citing works
Simpson, K. D., Templeton, D. J., & Cross, J. V. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201161 · Cited by 214 · see citing works
Macrophage Migration Inhibitory Factor: A Probable Link between Inflammation and Cancer
Bucala, R., & Donnelly, S. C. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.005 · Cited by 210 · see citing works
Inflammation and p53: A Tale of Two Stresses
Gudkov, A. V., Gurova, K. V., & Komarova, E. A. (2011) · Genes & Cancer · doi:10.1177/1947601911409747 · Cited by 204 · see citing works
Inflammation and cancer: macrophage migration inhibitory factor (MIF)--the potential missing link
Conroy, H., Mawhinney, L., & Donnelly, S. C. (2010) · QJM · doi:10.1093/qjmed/hcq148 · Cited by 201 · see citing works
Natural mechanisms protecting against cancer
Jakóbisiak, M., Lasek, W., & Gołąb, J. (2003) · Immunology Letters · doi:10.1016/j.imlet.2003.08.005 · Cited by 205 · see citing works
Avis, I. M., Hong, S. H., Martı́nez, A., Moody, T. W., Choi, Y. H., Trepel, J. B., Das, R., Jett, M., & Mulshine, J. L. (2001) · The FASEB Journal · doi:10.1096/fj.00-0866fje · Cited by 202 · see citing works
Nishihira, J. (2000) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900050151012 · Cited by 196 · see citing works
Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities
O’Reilly, C., Doroudian, M., Mawhinney, L., & Donnelly, S. C. (2016) · Medicinal Research Reviews · doi:10.1002/med.21385 · Cited by 182 · see citing works
Mechanisms of inflammatory responses to radiation and normal tissues toxicity: clinical implications
Najafi, M., Motevaseli, E., Shirazi, A., Geraily, G., Rezaeyan, A., Norouzi, F., Rezapoor, S., & Abdollahi, H. (2018) · International Journal of Radiation Biology · doi:10.1080/09553002.2018.1440092 · Cited by 182 · see citing works
Krockenberger, M., Dombrowski, Y., Weidler, C., Ossadnik, M., Hönig, A., Häusler, S. F., Voigt, H., Becker, J. C., Leng, L., Steinle, A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7338 · Cited by 179 · see citing works
D-dopachrome tautomerase (D-DT or MIF-2): Doubling the MIF cytokine family
Merk, M., Mitchell, R. A., Endres, S., & Bucala, R. (2012) · Cytokine · doi:10.1016/j.cyto.2012.03.014 · Cited by 178 · see citing works
Tumors are unique organs defined by abnormal signaling and context
Radisky, D. C., Hagios, C., & Bissell, M. J. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0360 · Cited by 177 · see citing works
Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF)
Mitchell, R. A., & Bucala, R. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0328 · Cited by 174 · see citing works
Méresse, S., Fodil, M., Fleury, F., & Chénais, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239273 · Cited by 171 · see citing works
Mishra, A., Liu, S., Sams, G. H., Curphey, D. P., Santhanam, R., Rush, L. J., Schaefer, D. M. W., Falkenberg, L. G., Sullivan, L., Jaroncyk, L., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.009 · Cited by 169 · see citing works
Senter, P. D., Al‐Abed, Y., Metz, C. N., Benigni, F., Mitchell, R. A., Chesney, J. A., Han, J., Gartner, C. G., Nelson, S. D., Todaro, G. J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011569399 · Cited by 169 · see citing works
The role of microRNAs in colorectal cancer
Liu, M., & Chen, H. (2010) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/s1673-8527(09)60053-9 · Cited by 165 · see citing works
Role of MIF Cytokine/CD74 Receptor Pathway in Protecting Against Injury and Promoting Repair
Farr, L., Ghosh, S., & Moonah, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01273 · Cited by 166 · see citing works
Chronic immune activation and inflammation in the pathogenesis of aids and cancer
Dalgleish, A. G., & O'Byrne, K. J. (2002) · Advances in cancer research · doi:10.1016/s0065-230x(02)84008-8 · Cited by 166 · see citing works
HIF1α delays premature senescence through the activation of MIFPreprint
Welford, S. M., Bedogni, B., Gradin, K., Poellinger, L., Powell, M. B., & Giaccia, A. J. (2006) · Genes & Development · doi:10.1101/gad.1471106 · Cited by 163 · see citing works
miRNA regulation of cytokine genes
Asirvatham, A. J., Magner, W. J., & Tomasi, T. B. (2009) · Cytokine · doi:10.1016/j.cyto.2008.11.010 · Cited by 161 · see citing works
At the Crossroads of Inflammation and Tumorigenesis
Cordon‐Cardo, C., & Prives, C. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1367 · Cited by 160 · see citing works
HIF1α Represses Cell Stress Pathways to Allow Proliferation of Hypoxic Fetal Cardiomyocytes
Guimarães‐Camboa, N., Stowe, J. C., Aneas, I., Sakabe, N. J., Cattaneo, P., Henderson, L. M., Kilberg, M. S., Johnson, R. S., Chen, J., McCulloch, A. D., et al. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.04.021 · Cited by 153 · see citing works
Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease
O’Connor, P. M. J., Lapointe, T. K., Beck, P. L., & Buret, A. G. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21217 · Cited by 151 · see citing works
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
Verjans, E., Noetzel, E., Bektas, N., Schütz, A. K., Lue, H., Lennartz, B., Hartmann, A., Dahl, E., & Bernhagen, J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-230 · Cited by 151 · see citing works
Macrophage Migration Inhibitory Factor Promotes Intestinal Tumorigenesis
Wilson, J. M., Coletta, P. L., Cuthbert, R. J., Scott, N. A., MacLennan, K., Hawcroft, G., Leng, L., Lubetsky, J. B., Jin, K. K., Lolis, E., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.07.061 · Cited by 146 · see citing works
Phosphorylation of p53 by IκB kinase 2 promotes its degradation by β-TrCP
Xia, Y., Padre, R. C., de Mendoza, T. H., Bottero, V., Tergaonkar, V., & Verma, I. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812256106 · Cited by 146 · see citing works
Inflammation, carcinogenesis and cancer
Fitzpatrick, F. A. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00102-3 · Cited by 146 · see citing works
Fingerle-Rowson, G., Kaleswarapu, D. R., Schlander, C., Kabgani, N., Brocks, T., Reinart, N., Busch, R. M., Schütz, A. K., Lue, H., Du, X., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01907-08 · Cited by 144 · see citing works
Glucose regulated protein 78: A critical link between tumor microenvironment and cancer hallmarks
Li, Z., & Li, Z. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.02.001 · Cited by 144 · see citing works
Apoptosis in cancer—implications for therapy
Schulze‐Bergkamen, H., & Krammer, P. H. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.11.006 · Cited by 144 · see citing works
Vennervald, B. J., & Polman, K. (2009) · Parasite Immunology · doi:10.1111/j.1365-3024.2009.01163.x · Cited by 142 · see citing works
Regulation of Joint Destruction and Inflammation by p53 in Collagen-Induced Arthritis
Yamanishi, Y., Boyle, D. L., Pinkoski, M. J., Mahboubi, A., Lin, T., Han, Z., Zvaifler, N. J., Green, D. R., & Firestein, G. S. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64356-8 · Cited by 141 · see citing works
Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease
Chen, L., Zhou, X., Fan, L. X., Yao, Y., Swenson-Fields, K. I., Gadjeva, M. G., Wallace, D. P., Peters, D. J. M., Yu, A. S. L., Grantham, J. J., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80467 · Cited by 139 · see citing works
Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer
Xu, X., Wang, B., Ye, C., Chen, Y., Lin, Y., Huang, X., Zhang, Y., & Wang, S. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.028 · Cited by 139 · see citing works
Hagemann, T., Robinson, S. D., Thompson, R. G., Charles, K. A., Kulbe, H., & Balkwill, F. R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0118 · Cited by 139 · see citing works
White, E. S., Flaherty, K. R., Carskadon, S. L., Brant, A., Iannettoni, M. D., Yee, J., Orringer, M. B., & Arenberg, D. A. (2003) · PubMed · Cited by 139 · see citing works
Role of MIF in Inflammation and Tumorigenesis
Bach, J., Rinn, B., Meyer, B., Dodel, R. C., & Bacher, M. (2008) · Oncology · doi:10.1159/000155223 · Cited by 138 · see citing works
Ren, Y., Tsui, H., Poon, R. T. P., Ng, I. O., Li, Z., Chen, Y., Jiang, G., Lau, C. P.-Y., Yu, W., Bacher, M., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11287 · Cited by 138 · see citing works
Macrophage Migration Inhibitory Factor (MIF)
Nishihira, J., Ishibashi, T., Fukushima, T., Sun, B., Sato, Y., & Todo, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03220.x · Cited by 138 · see citing works
Amin, A. R. M. R., Karpowicz, P. A., Carey, T. E., Arbiser, J. L., Nahta, R., Chen, Z. G., Dong, J., Küçük, Ö., Khan, G. N., Huang, G. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.005 · Cited by 136 · see citing works
Leng, L., Chen, L., Fan, J., Greven, D., Arjona, A., Du, X., Austin, D., Kashgarian, M. J., Yin, Z., Huang, X. R., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001767 · Cited by 136 · see citing works
The Cytokine Macrophage Migration Inhibitory Factor Reduces Pro-Oxidative Stress-Induced Apoptosis
Nguyen, M. T., Lue, H., Kleemann, R., Thiele, M., Tolle, G., Finkelmeier, D., Wagner, E., Braun, A. B., & Bernhagen, J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3337 · Cited by 136 · see citing works
Cui, Y. R., & Guo, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111942 · Cited by 135 · see citing works
Signal transduction in rheumatoid arthritis
Sweeney, S. E., & Firestein, G. S. (2004) · Current Opinion in Rheumatology · doi:10.1097/00002281-200405000-00011 · Cited by 135 · see citing works
Mechanisms and effectors of MIF-dependent promotion of tumourigenesis
Mitchell, R. A. (2003) · Cellular Signalling · doi:10.1016/j.cellsig.2003.07.002 · Cited by 134 · see citing works
Regulation of Macrophage Migration Inhibitory Factor Expression by Glucocorticoids in Vivo
Fingerle‐Rowson, G., Koch, P., Bikoff, R., Lin, X., Metz, C. N., Dhabhar, F. S., Meinhardt, A., & Bucala, R. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63797-2 · Cited by 134 · see citing works
- Authors
- Hudson, J. D., Shoaibi, M. A., Maestro, R., Carnero, A., Hannon, G. J., & Beach, D. H.
- Affiliations
- aUnit of Cancer Biology, Institute of Child Health, London WC1N 1EH, United Kingdom
- Centro di Riferimento Oncologico (IT)
- Cold Spring Harbor Laboratory (US)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1999-11-15
- Volume
- 190
- Issue
- 10
- Pages
- 1375-1382
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2195698
- OpenAlex
- W2110929110
- Cited by
- 649
- References
- 48
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 14 · 2023: 10 · 2022: 12 · 2021: 18 · 2020: 25 · 2019: 17 · 2018: 14 · 2017: 14 · 2016: 27 · 2015: 24 · 2014: 25 · 2013: 25 · 2012: 38
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, other-oa)
- Funders
- University College London
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Macrophage Migration Inhibitory Factor
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- p53, macrophage migration inhibitory factor, inflammatory cytokines, tumor suppressor inactivation, inflammation and tumorigenesis, p53 transcriptional activation, apoptosis, cell proliferation, genome stability
- MeSH terms
- Animals, Cell Line, Chronic Disease, Fibroblasts, Inflammation, Macrophage Migration-Inhibitory Factors, Neoplasms, Nitric Oxide, Transcriptional Activation, Tumor Suppressor Protein p53, Apoptosis, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review